Antibodies to OPGL
US7364736B2 · kind B2 · utility
59Cited by
125References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 25, 2002 |
| Grant date | Apr 29, 2008 |
| Priority date | — |
| Expiry date | Nov 28, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are described. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.